September 15, 2022 Ulike Co., Ltd ℅ Sun Cindy Senior Consultant PureVision Ai, Inc. 111 Town Square Place, Suite 1203 New Jers
![The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important) The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important)](https://blog.greenlight.guru/hubfs/The%20Difference%20Between%20Intended%20Use%20and%20Indications%20of%20Use.png)
The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important)
![The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX ppt video online download The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX ppt video online download](https://slideplayer.com/slide/9485350/29/images/23/Intended+Use+and+Indications+for+Use.jpg)
The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX ppt video online download
![FDA's role in the innovation and evaluation of evolving computer-aided diagnosis (CAD) solutions Kyle J. Myers, Ph.D. Director, Division of Imaging, Diagnostics, - ppt download FDA's role in the innovation and evaluation of evolving computer-aided diagnosis (CAD) solutions Kyle J. Myers, Ph.D. Director, Division of Imaging, Diagnostics, - ppt download](https://slideplayer.com/slide/12512816/75/images/13/Intended+use+Intended+use+%E2%80%93+purpose+of+the+device+or+its+function.+The+intended+use+of+a+device+encompasses+the+indications+for+use..jpg)
FDA's role in the innovation and evaluation of evolving computer-aided diagnosis (CAD) solutions Kyle J. Myers, Ph.D. Director, Division of Imaging, Diagnostics, - ppt download
![FDA's Safety And Performance-based Pathway An Alternative To Substantial Equivalence For 510(k) Submissions FDA's Safety And Performance-based Pathway An Alternative To Substantial Equivalence For 510(k) Submissions](https://vertassets.blob.core.windows.net/image/ba09c7d1/ba09c7d1-f5ed-4612-852f-5599bbc6ae6b/g2.jpg)
FDA's Safety And Performance-based Pathway An Alternative To Substantial Equivalence For 510(k) Submissions
![The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important) The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important)](https://www.greenlight.guru/hs-fs/hubfs/(cover)%20A%20Complete%20Guide%20to%20Bringing%20a%20Medical%20Device%20to%20Market.png?width=4250&name=(cover)%20A%20Complete%20Guide%20to%20Bringing%20a%20Medical%20Device%20to%20Market.png)
The Difference Between Intended Use and Indications of Use (And Why These Statements Are So Important)
![How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage This Under-Utilized Tool to Help De-Risk your 510(k) | PPT How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage This Under-Utilized Tool to Help De-Risk your 510(k) | PPT](https://image.slidesharecdn.com/howtopreparefdapre-submissiondavidamorgreenlightguru-180720125645/85/how-to-prepare-for-and-make-the-most-out-of-your-fda-presubmission-leverage-this-underutilized-tool-to-help-derisk-your-510k-42-320.jpg)